Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Behan

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|August 24, 2018
Non-Hodgkin lymphomaAnna Bowzyk Al-Naeeb, Thankamma Ajithkumar, Sarah Behan, et al.
The Lancet. Oncology|December 14, 2024
The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational studyAnna Santarsieri, Emily Mitchell, My H Pham, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|August 24, 2018
Non-Hodgkin lymphomaAnna Bowzyk Al-Naeeb, Thankamma Ajithkumar, Sarah Behan, et al.
The Lancet. Oncology|December 14, 2024
The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational studyAnna Santarsieri, Emily Mitchell, My H Pham, et al.
Pageof 1